Published in Ann Am Thorac Soc on September 01, 2016
The microbiome-metabolome crosstalk in the pathogenesis of respiratory fungal diseases. Virulence (2016) 0.75
Bacterial biofilms: a common cause of persistent infections. Science (1999) 40.82
The biofilm matrix. Nat Rev Microbiol (2010) 12.60
Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature (2000) 10.32
Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med (2003) 9.78
Persister cells, dormancy and infectious disease. Nat Rev Microbiol (2006) 8.35
Extracellular DNA required for bacterial biofilm formation. Science (2002) 8.25
Bacterial biofilms: an emerging link to disease pathogenesis. Annu Rev Microbiol (2003) 7.29
The intercellular adhesion (ica) locus is present in Staphylococcus aureus and is required for biofilm formation. Infect Immun (1999) 7.22
Pseudomonas aeruginosa displays multiple phenotypes during development as a biofilm. J Bacteriol (2002) 6.98
Survival strategies of infectious biofilms. Trends Microbiol (2005) 6.73
Gene expression in Pseudomonas aeruginosa biofilms. Nature (2001) 6.70
Immune recognition. A new receptor for beta-glucans. Nature (2001) 6.54
Acinetobacter infection. N Engl J Med (2008) 6.47
Physiological heterogeneity in biofilms. Nat Rev Microbiol (2008) 5.89
Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob Agents Chemother (2003) 4.59
Bap, a Staphylococcus aureus surface protein involved in biofilm formation. J Bacteriol (2001) 4.18
Biofilm formation by Candida species on the surface of catheter materials in vitro. Infect Immun (1994) 4.15
Acyl-homoserine lactone quorum sensing in gram-negative bacteria: a signaling mechanism involved in associations with higher organisms. Proc Natl Acad Sci U S A (2000) 4.00
Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis. Infect Immun (1994) 3.83
Active starvation responses mediate antibiotic tolerance in biofilms and nutrient-limited bacteria. Science (2011) 3.66
Microbial sciences: the superficial life of microbes. Nature (2006) 3.45
Multiple sensors control reciprocal expression of Pseudomonas aeruginosa regulatory RNA and virulence genes. Proc Natl Acad Sci U S A (2005) 3.31
A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients. Proc Natl Acad Sci U S A (2008) 3.28
Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: the NASCENT randomized trial. JAMA (2008) 3.01
Biofilm matrix of Candida albicans and Candida tropicalis: chemical composition and role in drug resistance. J Med Microbiol (2006) 2.76
Putative role of beta-1,3 glucans in Candida albicans biofilm resistance. Antimicrob Agents Chemother (2006) 2.68
A novel Staphylococcus aureus biofilm phenotype mediated by the fibronectin-binding proteins, FnBPA and FnBPB. J Bacteriol (2008) 2.51
The exopolysaccharide alginate protects Pseudomonas aeruginosa biofilm bacteria from IFN-gamma-mediated macrophage killing. J Immunol (2005) 2.30
Immune recognition of Candida albicans beta-glucan by dectin-1. J Infect Dis (2007) 2.24
Staphylococcus aureus biofilms prevent macrophage phagocytosis and attenuate inflammation in vivo. J Immunol (2011) 2.16
Characterization of the importance of Staphylococcus epidermidis autolysin and polysaccharide intercellular adhesin in the pathogenesis of intravascular catheter-associated infection in a rat model. J Infect Dis (2001) 2.10
Dispersion as an important step in the Candida albicans biofilm developmental cycle. PLoS Pathog (2010) 2.09
The pel polysaccharide can serve a structural and protective role in the biofilm matrix of Pseudomonas aeruginosa. PLoS Pathog (2011) 2.04
Pseudomonas biofilm matrix composition and niche biology. FEMS Microbiol Rev (2012) 2.00
Staphylococcus epidermidis surfactant peptides promote biofilm maturation and dissemination of biofilm-associated infection in mice. J Clin Invest (2010) 2.00
Compromised host defense on Pseudomonas aeruginosa biofilms: characterization of neutrophil and biofilm interactions. J Immunol (2003) 1.99
Staphylococcal infections: mechanisms of biofilm maturation and detachment as critical determinants of pathogenicity. Annu Rev Med (2012) 1.96
Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis. J Clin Microbiol (2004) 1.91
A Candida biofilm-induced pathway for matrix glucan delivery: implications for drug resistance. PLoS Pathog (2012) 1.88
Implications of endotracheal tube biofilm for ventilator-associated pneumonia. Intensive Care Med (1999) 1.86
Microcolony formation: a novel biofilm model of Pseudomonas aeruginosa for the cystic fibrosis lung. J Med Microbiol (2005) 1.85
Protein A-mediated multicellular behavior in Staphylococcus aureus. J Bacteriol (2008) 1.81
The in vivo biofilm. Trends Microbiol (2013) 1.79
Technologic advances in endotracheal tubes for prevention of ventilator-associated pneumonia. Chest (2012) 1.77
Rabbit model of Candida albicans biofilm infection: liposomal amphotericin B antifungal lock therapy. Antimicrob Agents Chemother (2004) 1.73
An extracellular matrix glues together the aerial-grown hyphae of Aspergillus fumigatus. Cell Microbiol (2007) 1.73
Role of different routes of tracheal colonization in the development of pneumonia in patients receiving mechanical ventilation. Chest (1999) 1.70
Bacterial biofilm development as a multicellular adaptation: antibiotic resistance and new therapeutic strategies. Curr Opin Microbiol (2013) 1.63
Pseudomonas aeruginosa lectin LecB is located in the outer membrane and is involved in biofilm formation. Microbiology (2005) 1.59
Broad-spectrum anti-biofilm peptide that targets a cellular stress response. PLoS Pathog (2014) 1.58
Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults. Cochrane Database Syst Rev (2013) 1.58
In vivo biofilm composition of Aspergillus fumigatus. Cell Microbiol (2009) 1.58
The galactophilic lectin, LecA, contributes to biofilm development in Pseudomonas aeruginosa. Environ Microbiol (2006) 1.56
Biofouling in water systems--cases, causes and countermeasures. Appl Microbiol Biotechnol (2002) 1.56
Nucleotide, c-di-GMP, c-di-AMP, cGMP, cAMP, (p)ppGpp signaling in bacteria and implications in pathogenesis. Chem Soc Rev (2012) 1.53
Presence of biofilm containing viable multiresistant organisms despite terminal cleaning on clinical surfaces in an intensive care unit. J Hosp Infect (2011) 1.52
Key two-component regulatory systems that control biofilm formation in Pseudomonas aeruginosa. Environ Microbiol (2011) 1.47
Tracheal tube biofilm as a source of bacterial colonization of the lung. J Clin Microbiol (1989) 1.46
Tobramycin resistance of mucoid Pseudomonas aeruginosa biofilm grown under iron limitation. J Antimicrob Chemother (1989) 1.44
Towards diagnostic guidelines for biofilm-associated infections. FEMS Immunol Med Microbiol (2012) 1.43
The pathogenesis of catheter-related bloodstream infection with noncuffed short-term central venous catheters. Intensive Care Med (2003) 1.42
The presence and sequence of endotracheal tube colonization in patients undergoing mechanical ventilation. Eur Respir J (1999) 1.41
Microtiter susceptibility testing of microbes growing on peg lids: a miniaturized biofilm model for high-throughput screening. Nat Protoc (2010) 1.36
Aspergillus fumigatus forms biofilms with reduced antifungal drug susceptibility on bronchial epithelial cells. Antimicrob Agents Chemother (2008) 1.31
Presence of extracellular DNA in the Candida albicans biofilm matrix and its contribution to biofilms. Mycopathologia (2009) 1.31
Evaluation of caspofungin and amphotericin B deoxycholate against Candida albicans biofilms in an experimental intravascular catheter infection model. J Infect Dis (2006) 1.30
Sticky situations: key components that control bacterial surface attachment. J Bacteriol (2012) 1.27
Pseudomonas aeruginosa Psl polysaccharide reduces neutrophil phagocytosis and the oxidative response by limiting complement-mediated opsonization. Cell Microbiol (2011) 1.25
ESCMID guideline for the diagnosis and treatment of biofilm infections 2014. Clin Microbiol Infect (2015) 1.24
Conditions associated with the cystic fibrosis defect promote chronic Pseudomonas aeruginosa infection. Am J Respir Crit Care Med (2014) 1.19
Addition of DNase improves the in vitro activity of antifungal drugs against Candida albicans biofilms. Mycoses (2011) 1.18
D-enantiomeric peptides that eradicate wild-type and multidrug-resistant biofilms and protect against lethal Pseudomonas aeruginosa infections. Chem Biol (2015) 1.17
Molecular mechanisms of antimicrobial tolerance and resistance in bacterial and fungal biofilms. Trends Microbiol (2014) 1.17
Extracellular DNA shields against aminoglycosides in Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother (2013) 1.17
Health care-associated infections: major issues in the early years of the 21st century. Clin Infect Dis (2007) 1.15
Aspergillus galactosaminogalactan mediates adherence to host constituents and conceals hyphal β-glucan from the immune system. PLoS Pathog (2013) 1.15
From in vitro to in vivo Models of Bacterial Biofilm-Related Infections. Pathogens (2013) 1.15
The polymicrobial nature of biofilm infection. Clin Microbiol Infect (2012) 1.14
Identification of small molecules that antagonize diguanylate cyclase enzymes to inhibit biofilm formation. Antimicrob Agents Chemother (2012) 1.14
Relacin, a novel antibacterial agent targeting the Stringent Response. PLoS Pathog (2012) 1.14
Implications of endotracheal tube biofilm in ventilator-associated pneumonia response: a state of concept. Crit Care (2012) 1.14
New methods for the detection of orthopedic and other biofilm infections. FEMS Immunol Med Microbiol (2011) 1.14
Novel entries in a fungal biofilm matrix encyclopedia. MBio (2014) 1.13
Extracellular DNA release acts as an antifungal resistance mechanism in mature Aspergillus fumigatus biofilms. Eukaryot Cell (2013) 1.13
Mechanisms of Candida biofilm drug resistance. Future Microbiol (2013) 1.13
Efficacy of common hospital biocides with biofilms of multi-drug resistant clinical isolates. J Med Microbiol (2008) 1.10
Host defence against Staphylococcus aureus biofilms infection: phagocytosis of biofilms by polymorphonuclear neutrophils (PMN). Mol Immunol (2009) 1.10
Comparative antibody-mediated phagocytosis of Staphylococcus epidermidis cells grown in a biofilm or in the planktonic state. Infect Immun (2006) 1.10
Mechanisms of phagocytosis and host clearance of Pseudomonas aeruginosa. Am J Physiol Lung Cell Mol Physiol (2014) 1.09
Interactions in multispecies biofilms: do they actually matter? Trends Microbiol (2014) 1.07
Pel is a cationic exopolysaccharide that cross-links extracellular DNA in the Pseudomonas aeruginosa biofilm matrix. Proc Natl Acad Sci U S A (2015) 1.06
Importance of DNase and alginate lyase for enhancing free and liposome encapsulated aminoglycoside activity against Pseudomonas aeruginosa. J Antimicrob Chemother (2009) 1.06
Interactions between human phagocytes and Candida albicans biofilms alone and in combination with antifungal agents. J Infect Dis (2010) 1.05
Biofilms and Cyclic di-GMP (c-di-GMP) Signaling: Lessons from Pseudomonas aeruginosa and Other Bacteria. J Biol Chem (2016) 1.02
Assessment of microbial diversity in biofilms recovered from endotracheal tubes using culture dependent and independent approaches. PLoS One (2012) 1.02
Inhaled antibiotics for lower airway infections. Ann Am Thorac Soc (2014) 1.00
Quorum sensing inhibitors as anti-biofilm agents. Curr Pharm Des (2015) 0.99
Anti-biofilm activity of silver nanoparticles against different microorganisms. Biofouling (2013) 0.99
Candida albicans biofilms do not trigger reactive oxygen species and evade neutrophil killing. J Infect Dis (2012) 0.96
Polysaccharide intercellular adhesin in biofilm: structural and regulatory aspects. Front Cell Infect Microbiol (2015) 0.96